$PULM $JNJ The shift to iSPERSE for JnJ is more than just PUR1800. If successful, JnJ will look to apply iSPERSE to more and more of their portfolio, as well as alternative delivery techniques for therapeutics and vaccines. This is a new day for medicine.
2
1
15
15 Likes